Differential Role of Active Compounds in Mitophagy and Related Neurodegenerative Diseases

Mark Makarov, Eduard Korkotian*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

Neurodegenerative diseases, such as Alzheimer's disease or Parkinson's disease, significantly reduce the quality of life of patients and eventually result in complete maladjustment. Disruption of the synapses leads to a deterioration in the communication of nerve cells and decreased plasticity, which is associated with a loss of cognitive functions and neurodegeneration. Maintaining proper synaptic activity depends on the qualitative composition of mitochondria, because synaptic processes require sufficient energy supply and fine calcium regulation. The maintenance of the qualitative composition of mitochondria occurs due to mitophagy. The regulation of mitophagy is usually based on several internal mechanisms, as well as on signals and substances coming from outside the cell. These substances may directly or indirectly enhance or weaken mitophagy. In this review, we have considered the role of some compounds in process of mitophagy and neurodegeneration. Some of them have a beneficial effect on the functions of mitochondria and enhance mitophagy, showing promise as novel drugs for the treatment of neurodegenerative pathologies, while others contribute to a decrease in mitophagy.
Original languageEnglish
Article number202
Number of pages23
JournalToxins
Volume15
Issue number3
DOIs
Publication statusPublished - 6 Mar 2023

Bibliographical note

The authors thank Menahem Segal and Philip Freund for constructive comments during the preparation of the manuscript.
This research received no external funding.

Fingerprint

Dive into the research topics of 'Differential Role of Active Compounds in Mitophagy and Related Neurodegenerative Diseases'. Together they form a unique fingerprint.

Cite this